Poster 029, Table 1.

Outcome of Non-responding Patients to Anti-TNF Therapy.

Non-responders Laboratory ResultsINF/ADA (pts)DiscontinuedContinued
Low INF/ADA levels,6/63: allergic reaction3: shortening intervals
High anti-INF abs/anti-ADA abs6: inefficiency2: methotrexate renewal
Low INF/ADA levels,12/51: allergic reaction15: shortening intervals
Low anti-INFabs/anti-ADA abs1: inefficiency
High INF/ADA levels,6/92: inefficiency13: improved
Low anti-INF abs/anti-ADA abs

INF-infliximab, ADA-adalimumab, abs-antibodies.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2015 January; 6(1): e0009. ISSN: 2076-9172
Published online 2015 January 29. doi: 10.5041/RMMJ.10184.